Please login to the form below

cHL

This page shows the latest cHL news and features for those working in and with pharma, biotech and healthcare.

Keytruda doubles five-year survival rate in NSCLC

Since then, the immunotherapy has added an array of indications to its arsenal, including approvals for the treatment of head and neck squamous cell carcinoma, classical Hodgkin lymphoma (cHL), cervical cancer,

Latest news

Eli Lilly, Innovent showcase Tyvyt data in first-line NSCLC

Tyvyt has also been approved in China for the treatment of relapsed or refractory classical Hodgkin’s lymphoma (cHL).
Keytruda hits primary endpoint in confirmatory lymphoma trial

CHL is, in comparison to Keytruda’s other indications, not quite as important. ... That includes evaluating Keytruda in combination with chemotherapy in children and young adults in first-line cHL and in the post-Adcetris treatment setting.
Innovent gears up for PD-1 inhibitor launch in China

cHL) in December.
China’s BeiGene takes PD-1 antibody into pivotal trials

The single-arm trial enrolled 70 cHL patients who had failed autologous stem cell transplantation (ASCT) – a primary treatment for the cancer – or were ineligible for the procedure.
Merck suspends two Keytruda trials after patient deaths

Earlier this year Keytruda was approved for classical Hodgkin lymphoma (cHL) - its first non-solid tumour indication - and expanding into blood cancers is a key target for Merck.

More from news
Approximately 2 fully matching, plus 10 partially matching documents found.

Latest Intelligence

Chinese biotech’s global ambitions

CDA). The company is filing first for patients with relapsed/refractory classical Hodgkin’s lymphoma (R/R cHL) – a niche indication not yet taken in China by Keytruda and Opdivo, which

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Associate Medical Writer / Entry Level Medical Writer - Medical ...: DOE

Client Services Director +, Remote or London – Leadership Opport...: Highly Competitive Salary, Bonus &Benefits

FREELANCE (Outside IR35) Opportunities for this week below!!!: Superb Day Rate

Account Manager - Healthcare Consultancy: Salary depending on experience

Senior Account Director & Associate Director - Healthcare Ad...: Highly Competitive Salary, Bonus &Benefits

Digital strategist: Competitive

Home Working Medical Copy Writer & Senior Medical Copy Write...: Highly Competitive Salary, Bonus &Benefits

Digital account director: Competitive

Editor & Senior Editor - Medical Communications - Home Based: Highly Competitive Salary, Bonus &Benefits

Digital project manager: Competitive

FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...: Highly Competitive Day Rate, Bonus &Benefits

Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...: Highly competitive salary

PMHub

Add my company

fox&cat

up to your ears in it? some pressure is helpful but too much of the wrong sort quickly takes its...

Latest intelligence

The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel: Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor: Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story: Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....

Email:
Password:

Please login to the form below

cHL

COVID-19 Updates and Daily News

Featured jobs

Quick links